Comprehensive examination of horse welfare in racing industries worldwide, covering injury rates, training practices, drug use, and welfare reform initiatives.
Horse racing involves approximately 700,000 Thoroughbreds and other breeds globally in regulated racing industries across over 100 countries. The sport generates tens of billions in economic activity but has faced intensifying welfare scrutiny over injury rates, drug use, early training of young horses, and retirement practices. Recent years have seen significant regulatory reforms in major racing nations.
Musculoskeletal injuries—particularly catastrophic fractures—are the primary welfare concern in horse racing. In the US, approximately 1.5-2 fatalities per 1,000 starts occur on synthetic and turf tracks, rising to 2-3 on dirt. California's Santa Anita Park experienced a crisis period in 2019 with 30 horse deaths in a single season, prompting emergency regulatory action. The UK has lower fatality rates (approximately 0.4-0.6 per 1,000 starts on flat, higher in jump racing), attributed to stricter medication controls and racecourse management. Jump racing (steeplechase and hurdle) carries significantly higher injury risk than flat racing.
Sub-catastrophic injuries—tendon strain, bone stress reactions, joint disease—affect a much larger proportion of racehorses and cause significant welfare impact that is less visible than fatalities. Many horses race through pain managed with medication rather than given appropriate rest.
The use of therapeutic medications in horse racing is heavily contested. Furosemide (Lasix), a diuretic used to prevent exercise-induced pulmonary hemorrhage (EIPH), is permitted on race day in most US states but prohibited in international racing. Critics argue its mask of bleeding allows horses with underlying conditions to race when they should rest. Corticosteroid joint injections can mask pain and allow horses to compete through injuries. The Horseracing Integrity and Safety Act (HISA) established federal oversight of US racing drug regulations from 2022, aiming to create uniform national standards.
Thoroughbreds enter training at approximately 18 months and begin racing at age 2, when skeletal development is incomplete. Evidence suggests that the immature skeleton is vulnerable to stress-related damage during this period. Some researchers and advocates argue for delaying racing debut to age 3. Early retirement of horses that fail to make it as racehorses is another welfare concern, with many horses discarded into uncertain futures.
The welfare of retired racehorses is a significant concern. In the US, an estimated 150,000 Thoroughbreds exit racing annually. The Thoroughbred Aftercare Alliance accredits retirement facilities, but capacity is insufficient to accommodate all retired horses humanely. Some retired racehorses are sent to slaughter—a practice legal in Mexico and Canada. The Second Chances program and various retraining organizations prepare ex-racehorses for second careers as riding horses.
Major reform initiatives include pre-race veterinary inspections, track surface improvements, enhanced imaging programs to detect subclinical bone changes before catastrophic failure, national uniform drug testing (HISA in US), and mandatory retirement support levies. Ireland's Equine Welfare Fund, funded by racing industry stakeholders, supports retirement facilities. The British Horseracing Authority's Horse Welfare Board has adopted a comprehensive Five Year Strategy addressing welfare throughout horses' lives.
Public concern about horse welfare has contributed to declining racing attendance and wagering in some markets. The sport faces a legitimacy crisis if welfare issues are not credibly addressed. Industry investment in welfare research—including the Racing Foundation in the UK funding injury prevention research—signals growing recognition that welfare reform is necessary for the sport's social license to operate.
← Back to Animal Welfare Hub